Julie Eastland

Julie Eastland

DirectoratZentalis Pharmaceuticals· In proxies 2024–2025

Pay in FY2024Zentalis Pharmaceuticals stock -80.0% the same year

Julie Eastland was paid $8.2M in FY2024 (Dec). Zentalis Pharmaceuticals stock fell 80.0% that year.

Pay$100 in the stock at the end of FY23 → $20
Pay is from the Summary Compensation Table of each Zentalis Pharmaceuticals proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Lantheus HoldingsPublic company · 2 yr
    • Director2024 – Present · 2 yrNo stock prices for these years
  2. Zentalis PharmaceuticalsPublic company · 2 yr
    • President and Chief Executive Officer2024 – Present · 2 yrStock in role -87%
  3. Harpoon TherapeuticsPublic company · 8 yr
    • Director2018 – Present · 8 yrNo stock prices for these years
  4. Seismic Therapeutic, Inc.Public company
    • Director? – PresentNo stock prices for these years
  5. Dynavax Technologies CorporationPublic company
    • Director? – 2025No stock prices for these years
  6. Graybug VisionPublic company · 3 yr
    • Director2020 – 2023 · 3 yrNo stock prices for these years

Roles come from the proxy statements of each company.

Boards1

  • Lantheus HoldingsDirector · 0 yr on the boardIndependentAudit—Paid as an executive

Board seats come from each company's latest proxy statement.

Activity

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?